Department of Hepatobiliary Surgery
Yinghai Xie has not added Biography.
If you are Yinghai Xie and would like to personalize this page please email our Author Liaison for assistance.
PKI-587 enhances chemosensitivity of oxaliplatin in hepatocellular carcinoma through suppressing DNA damage repair pathway (NHEJ and HR) and PI3K/AKT/mTOR pathway.
American journal of translational research , 2019 | Pubmed ID: 31497229
BEZ235 increases sorafenib inhibition of hepatocellular carcinoma cells by suppressing the PI3K/AKT/mTOR pathway.
American journal of translational research , 2019 | Pubmed ID: 31632530
BEZ235 enhances chemosensitivity of paclitaxel in hepatocellular carcinoma through inhibiting the PI3K/Akt/mTOR pathway.
American journal of translational research , 2019 | Pubmed ID: 31934276
The PI3K/mTOR dual inhibitor BEZ235 nanoparticles improve radiosensitization of hepatoma cells through apoptosis and regulation DNA repair pathway.
Nanoscale research letters Mar, 2020 | Pubmed ID: 32219609
LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells.
International journal of medical sciences , 2021 | Pubmed ID: 33628103
BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy.
BioMed research international , 2021 | Pubmed ID: 33987439
PKI-587 enhances radiosensitization of hepatocellular carcinoma by inhibiting the PI3K/AKT/mTOR pathways and DNA damage repair.
PloS one , 2021 | Pubmed ID: 34665844
Lupeol-Loaded Nanoparticles Enhance the Radiosensitivity of Hepatocellular Carcinoma by Inhibiting the Hyperactivation in Raf/Mitogen-Activated Protein Kinase and Phospatidylinositol-3 Kinase/mTOR Pathways.
Journal of biomedical nanotechnology Nov, 2021 | Pubmed ID: 34906285
Retraction Note: The PI3K/mTOR Dual Inhibitor BEZ235 Nanoparticles Improve Radiosensitization of Hepatoma Cells Through Apoptosis and Regulation DNA Repair Pathway.
Nanoscale research letters Dec, 2021 | Pubmed ID: 34914025
ASIC1a stimulates the resistance of human hepatocellular carcinoma by promoting EMT via the AKT/GSK3β/Snail pathway driven by TGFβ/Smad signals.
Journal of cellular and molecular medicine May, 2022 | Pubmed ID: 35426224
ASIC1α up-regulates MMP-2/9 expression to enhance mobility and proliferation of liver cancer cells via the PI3K/AKT/mTOR pathway.
BMC cancer Jul, 2022 | Pubmed ID: 35840921
Lei Xu*,1,2,
Manman Xu*,3,
Yinghai Xie4,
Wei You2,
Jianxin Wang2,
Liwu Xu4,
Qizhu Feng4,
Jie Sun4,
Jian Zhang4,
Huaichen Yang4,
Wang Qi4
1, The First Affiliated Hospital of Anhui University of Science & Technology,
2, Medical College of Anhui University of Science & Technology,
3Endocrinology Department, The First Affiliated Hospital of Anhui University of Science & Technology,
4Department of Hepatobiliary Surgery, The First Affiliated Hospital of Anhui University of Science & Technology
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。